Inherited acute myeloid leukemia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:319465OMIM:601626C92.0
Who is this for?
Show terms as
1FDA treatments2Active trials23Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Inherited acute myeloid leukemia (AML) is a rare form of blood cancer that runs in families. Unlike most cases of AML, which occur without a clear inherited cause, this form is passed down through families due to changes (mutations) in specific genes. These gene mutations increase the risk of developing AML, a cancer where the bone marrow makes too many abnormal white blood cells. These abnormal cells crowd out healthy blood cells, leading to problems like frequent infections, easy bruising or bleeding, fatigue, and anemia. People with inherited AML may develop the disease at a younger age than those with non-inherited forms. Some families may notice that multiple relatives have been diagnosed with AML or other blood cancers. The condition can also be associated with other blood disorders, such as myelodysplastic syndrome (MDS), which may develop before full-blown leukemia appears. Treatment for inherited AML is similar to other forms of AML and typically involves intensive chemotherapy to destroy the cancer cells, followed by a bone marrow (stem cell) transplant when possible. Because this is an inherited condition, family members may also need genetic testing and monitoring. Early detection through regular blood tests can be important for at-risk family members. Genetic counseling is strongly recommended for affected families to understand the risks and plan appropriate screening. Research is ongoing to better understand the specific genetic causes and to develop more targeted treatments.

Also known as:

Key symptoms:

Extreme tiredness and fatigueFrequent or severe infectionsEasy bruisingUnusual or prolonged bleedingPale skin due to anemiaShortness of breathUnexplained feversBone or joint painSwollen lymph nodesUnintended weight lossNight sweatsSmall red or purple spots on the skin (petechiae)Feeling full or discomfort in the abdomen due to enlarged spleen

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

FDA & Trial Timeline

2 events
Dec 2020Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

Gruppo Italiano Malattie EMatologiche dell'Adulto

TrialRECRUITING
Feb 2017Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

1 available

Mylotarg

Gemtuzumab ozogamicin· Wyeth Pharmaceuticals, Inc., a Pfizer Company■ Boxed Warning

treatment of newly-diagnosed CD33-positive acute myeloid leukemia (AML) in adults and pediatric patients 1 month and older

Clinical Trials

2 recruitingView all trials with filters →
Other2 trials
Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes
Actively Recruiting
PI: Domenico Russo, MD (Chair of Hematology) · Sites: Brescia
Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms
Actively Recruiting
· Sites: Alessandria; Ancona +25 more · Age: 1899 yrs

Specialists

23 foundView all specialists →
GM
Guido Marcucci
DUARTE, CA
Specialist
PI on 5 active trials9 Inherited acute myeloid leukemia publications
CD
Colleen Delaney
OLD GREENWICH, CT
Specialist
PI on 3 active trials
TM
Thomas G. Martin, MD
Specialist
PI on 4 active trials
MS
Mikkael A Sekeres
MIAMI, FL
Specialist
PI on 1 active trial3 Inherited acute myeloid leukemia publications
PM
Paul Martin
Specialist
PI on 3 active trials73 Inherited acute myeloid leukemia publications
FG
Francis Giles
SAN ANTONIO, TX
Specialist
PI on 4 active trials
DM
Denis Claude Roy, Prof MD
PORTLAND, OR
Specialist
PI on 3 active trials
CM
Cheryl L. Willman, MD
ALBUQUERQUE, TX
Specialist
PI on 2 active trials
TP
Thomas R. Chauncey, MD, PhD
SEATTLE, WA
Specialist
PI on 3 active trials
MB
Merav Bar
SEATTLE, WA
Specialist
PI on 1 active trial2 Inherited acute myeloid leukemia publications
DM
Derek L. Stirewalt, MD
SEATTLE, WA
Specialist
PI on 2 active trials
YM
Yi-Bin A Chen, M.D.
BOSTON, MA
Specialist
PI on 1 active trial
AW
Ann Woolfrey
SEATTLE, WA
Specialist
PI on 5 active trials
FP
Fabio CICERI, MD, Pr.
Specialist
PI on 1 active trial
DR
Domenico Russo
Specialist
PI on 2 active trials
AP
Andrew Pecora
EGG HARBOR TOWNSHIP, NJ
Specialist
PI on 1 active trial
HK
Hee-Je Kim
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Mylotarg(Gemtuzumab ozogamicin)Wyeth Pharmaceuticals, Inc., a Pfizer Company

Travel Grants

No travel grants are currently matched to Inherited acute myeloid leukemia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Inherited acute myeloid leukemiaForum →

No community posts yet. Be the first to share your experience with Inherited acute myeloid leukemia.

Start the conversation →

Latest news about Inherited acute myeloid leukemia

Disease timeline:

New recruiting trial: Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes

A new clinical trial is recruiting patients for Inherited acute myeloid leukemia

New recruiting trial: Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

A new clinical trial is recruiting patients for Inherited acute myeloid leukemia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Which specific gene mutation is causing the inherited AML in our family?,Should other family members be tested for this genetic mutation?,Is a bone marrow transplant recommended, and can family members safely be donors?,What is the risk of the leukemia coming back after treatment?,How often should at-risk family members have blood tests or other screening?,Are there any clinical trials specifically for inherited forms of AML?,What long-term follow-up care will be needed after treatment?

Common questions about Inherited acute myeloid leukemia

What is Inherited acute myeloid leukemia?

Inherited acute myeloid leukemia (AML) is a rare form of blood cancer that runs in families. Unlike most cases of AML, which occur without a clear inherited cause, this form is passed down through families due to changes (mutations) in specific genes. These gene mutations increase the risk of developing AML, a cancer where the bone marrow makes too many abnormal white blood cells. These abnormal cells crowd out healthy blood cells, leading to problems like frequent infections, easy bruising or bleeding, fatigue, and anemia. People with inherited AML may develop the disease at a younger age th

How is Inherited acute myeloid leukemia inherited?

Inherited acute myeloid leukemia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Are there clinical trials for Inherited acute myeloid leukemia?

Yes — 2 recruiting clinical trials are currently listed for Inherited acute myeloid leukemia on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Inherited acute myeloid leukemia?

23 specialists and care centers treating Inherited acute myeloid leukemia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.